PMC:4277126 / 77015-77430 JSONTXT

{"project":"NEUROSES","denotations":[{"id":"T1649","span":{"begin":121,"end":133},"obj":"PATO_0002104"},{"id":"T1650","span":{"begin":275,"end":278},"obj":"CHEBI_32402"},{"id":"T1651","span":{"begin":280,"end":283},"obj":"CHEBI_16856"},{"id":"T1652","span":{"begin":285,"end":290},"obj":"CHEBI_47775"},{"id":"T1653","span":{"begin":327,"end":332},"obj":"CHEBI_47774"},{"id":"T1654","span":{"begin":337,"end":340},"obj":"CHEBI_566274"}],"text":"Summary on the hepatoprotective effects of LBPs\nTaken together, LBPs can substantially reduce oxidative stress, suppress inflammatory responses, and inhibit apoptosis to protect liver from injuries due to various insults. LBPs increase the levels and activities of GPx, SOD, CAT, GSH, HDL-C, and AMPK, but reduce the levels of LDL-C and MDA via modulation of p53-, SREBP-1c-, and NF-κB-mediated pathways (Figure 7)."}